Odds of Severe COVID-19 High for Hematologic Cancer Patients During Pandemic
THURSDAY, Feb. 29, 2024 -- For patients with hematologic cancers, the odds of developing severe COVID-19 despite vaccination remained high through mid-2022, according to a study published online Feb. 23 in JAMA Network Open.
Sonia T. Anand, Ph.D.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Covid Vaccine | COVID-19 | Hematology | Pandemics | Pharmaceuticals | Study | Vaccines